JP2016536271A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536271A5 JP2016536271A5 JP2016516087A JP2016516087A JP2016536271A5 JP 2016536271 A5 JP2016536271 A5 JP 2016536271A5 JP 2016516087 A JP2016516087 A JP 2016516087A JP 2016516087 A JP2016516087 A JP 2016516087A JP 2016536271 A5 JP2016536271 A5 JP 2016536271A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- topical composition
- antifungal agent
- nanoparticles
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 34
- 230000000699 topical effect Effects 0.000 claims description 28
- 229940121375 antifungal agent Drugs 0.000 claims description 23
- 239000003429 antifungal agent Substances 0.000 claims description 23
- 239000002105 nanoparticle Substances 0.000 claims description 15
- 229920002413 Polyhexanide Polymers 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 11
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 8
- 206010017533 Fungal infection Diseases 0.000 claims description 7
- 206010034016 Paronychia Diseases 0.000 claims description 6
- 206010017543 Fungal skin infection Diseases 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 2
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 claims description 2
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 2
- 208000007163 Dermatomycoses Diseases 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 2
- 229960003942 amphotericin b Drugs 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims description 2
- 229940093265 berberine Drugs 0.000 claims description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229960004130 itraconazole Drugs 0.000 claims description 2
- 229960004125 ketoconazole Drugs 0.000 claims description 2
- 229960000988 nystatin Drugs 0.000 claims description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000002195 synergetic effect Effects 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims description 2
- 229960002722 terbinafine Drugs 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 description 5
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1317005.5 | 2013-09-25 | ||
| GBGB1317005.5A GB201317005D0 (en) | 2013-09-25 | 2013-09-25 | Composition and methods of treatment |
| GBGB1320723.8A GB201320723D0 (en) | 2013-09-25 | 2013-11-25 | Composition and methods of treatment |
| GB1320723.8 | 2013-11-25 | ||
| PCT/GB2014/052911 WO2015044669A1 (en) | 2013-09-25 | 2014-09-25 | Antifungal topical composition and methods of treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019158280A Division JP7028836B2 (ja) | 2013-09-25 | 2019-08-30 | 抗真菌局所組成物および処置の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536271A JP2016536271A (ja) | 2016-11-24 |
| JP2016536271A5 true JP2016536271A5 (cg-RX-API-DMAC7.html) | 2017-11-02 |
| JP6581569B2 JP6581569B2 (ja) | 2019-09-25 |
Family
ID=49553377
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516087A Active JP6581569B2 (ja) | 2013-09-25 | 2014-09-25 | 抗真菌局所組成物および処置の方法 |
| JP2019158280A Active JP7028836B2 (ja) | 2013-09-25 | 2019-08-30 | 抗真菌局所組成物および処置の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019158280A Active JP7028836B2 (ja) | 2013-09-25 | 2019-08-30 | 抗真菌局所組成物および処置の方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11185511B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP3501498B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6581569B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105579028B (cg-RX-API-DMAC7.html) |
| CY (1) | CY1123414T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3049056T4 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2859518T3 (cg-RX-API-DMAC7.html) |
| GB (2) | GB201317005D0 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20191304T4 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE044589T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT3049056T (cg-RX-API-DMAC7.html) |
| PL (1) | PL3049056T5 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3049056T (cg-RX-API-DMAC7.html) |
| RS (1) | RS59211B2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI3049056T2 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT201900437T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015044669A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201317005D0 (en) * | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| US11110071B2 (en) * | 2015-06-19 | 2021-09-07 | Global Health Solutions Llc | Petrolatum-based PHMB compositions and methods of treatment for onychomycosis |
| US12290599B2 (en) | 2015-06-19 | 2025-05-06 | Global Health Solutions Llc | Oil-based wound care compositions and methods |
| GB201511799D0 (en) | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| PL3393518T3 (pl) * | 2015-12-23 | 2025-02-17 | Aarhus Universitet | Środek przeciwgrzybiczy |
| WO2017163072A1 (en) * | 2016-03-24 | 2017-09-28 | Locate Therapeutics Limited | Scaffolding material, methods and uses |
| GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| JP6310977B2 (ja) * | 2016-09-07 | 2018-04-11 | 株式会社日本総合研究所 | 爪用シール及びシールシート |
| WO2018162271A1 (en) | 2017-03-05 | 2018-09-13 | Rita Dobmeyer | Nanoparticles for the treatment of macular degeneration |
| GB201710491D0 (en) * | 2017-06-30 | 2017-08-16 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| KR102060138B1 (ko) * | 2018-05-30 | 2019-12-27 | 연세대학교 산학협력단 | 안구용 마이크로니들 주사의 제조방법 |
| GB201810923D0 (en) * | 2018-07-03 | 2018-08-15 | Blueberry Therapeutics Ltd | Compositions and method of treatment |
| GB201810925D0 (en) * | 2018-07-03 | 2018-08-15 | Blueberry Therapeutics Ltd | Compositions and methods of treatment |
| US12115139B2 (en) * | 2018-08-15 | 2024-10-15 | Todd Alan Weinfield | Treatment methods and processes for an infected nail |
| EP3911306B1 (en) * | 2019-01-16 | 2023-12-20 | Global Health Solutions, LLC | Petrolatum-based phmb compositions and methods of treatment for onychomycosis |
| GB201908229D0 (en) * | 2019-06-10 | 2019-07-24 | Univ College Cork National Univ Of Ireland | Microneedles and methods for the manufacture thereof |
| CN110898075B (zh) * | 2019-12-27 | 2021-08-03 | 温海 | 聚六亚甲基双胍在制备抑制和/或杀灭犬小孢子菌的药物中的应用 |
| CN111067897A (zh) * | 2020-01-20 | 2020-04-28 | 中山大学 | 一种抗真菌的组合物及其应用 |
| IL295800A (en) * | 2020-02-26 | 2022-10-01 | Biosergen As | Pharmaceutical compositions of a therapeutic polyene macrolide and methods of their use |
| CN111588689B (zh) * | 2020-06-20 | 2023-08-11 | 温州医科大学 | 一种角膜微创可溶性微针贴片及其制备方法与应用 |
| CN112168845A (zh) * | 2020-11-13 | 2021-01-05 | 郑虹 | 一种用于治疗手足癣的药物软膏及其制备方法 |
| JP2022118704A (ja) * | 2021-02-02 | 2022-08-15 | 国立大学法人 鹿児島大学 | ナノ粒子組成物、抗菌抗かび抗ウイルス剤、抗菌抗かび抗ウイルス塗料、抗菌抗かび抗ウイルス剤調製キット及びナノ粒子組成物の製造方法 |
| DE102021118997A1 (de) * | 2021-07-22 | 2023-01-26 | Lts Lohmann Therapie-Systeme Ag. | Mikronadelarray mit Antiseptika |
| CN113567217A (zh) * | 2021-07-27 | 2021-10-29 | 肖波 | 一种妇科荧光染色液 |
| EP4475895A1 (en) * | 2022-02-11 | 2024-12-18 | Fairleigh Dickinson University | Locally administered compositions and methods of use thereof |
| KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761886B1 (fr) * | 1997-04-14 | 2000-05-05 | Virbac Sa | Compositions contenant au moins un polymere cationique et au moins une molecule active contenue dans au moins un vecteur micro ou nanoparticulaire, et leur utilisation pour le traitement de surfaces vivantes ou inertes |
| US20020009491A1 (en) | 2000-02-14 | 2002-01-24 | Rothbard Jonathan B. | Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| EP1635770B1 (en) * | 2003-03-21 | 2009-05-27 | Nexmed Holdings, Inc. | Antifungal nail coat and method of use |
| CN102319409A (zh) * | 2003-07-17 | 2012-01-18 | 纽约市哥伦比亚大学托管会 | 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物 |
| US20050238672A1 (en) * | 2004-04-27 | 2005-10-27 | Nimni Marcel E | Antifungal drug delivery |
| WO2005115417A2 (en) * | 2004-05-03 | 2005-12-08 | Neosil, Inc. | Polycationic antimicrobial therapeutic |
| WO2006138719A2 (en) * | 2005-06-17 | 2006-12-28 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
| JP2008543528A (ja) | 2005-06-27 | 2008-12-04 | スリーエム イノベイティブ プロパティズ カンパニー | マイクロニードルカートリッジアセンブリ及び適用方法 |
| EP1909868A1 (en) * | 2005-07-25 | 2008-04-16 | Nanotechnology Victoria PTY Ltd | Microarray device |
| US20070249546A1 (en) * | 2006-04-22 | 2007-10-25 | Sawaya Assad S | Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them |
| CN101500937A (zh) | 2006-08-11 | 2009-08-05 | 万能药生物有限公司 | 用于递送活性成分的粒子及其制备方法和组合物 |
| CA2665343C (en) * | 2006-10-05 | 2014-12-16 | The Johns Hopkins University | Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| US20100021530A1 (en) * | 2008-07-25 | 2010-01-28 | Innovation Biomedical Devices, Inc. | Enhanced trans-keratin drug delivery |
| CN101724284B (zh) * | 2008-10-31 | 2012-06-27 | 中国石油化工股份有限公司 | 一种抗菌热塑性塑料组合物及其制备方法 |
| JP5408592B2 (ja) * | 2010-03-19 | 2014-02-05 | コスメディ製薬株式会社 | マイクロニードルの迅速溶解法 |
| JP2012235899A (ja) * | 2011-05-12 | 2012-12-06 | Bioserentack Co Ltd | 大量の目的物質を皮膚内へデリバリーするためのマイクロニードル・アレイ・チップ |
| KR20140057414A (ko) | 2011-06-22 | 2014-05-12 | 바이옴 바이오사이언스 피브이티. 엘티디. | 컨쥬게이트계 항진균 및 항세균 프로드러그 |
| GB201117538D0 (en) * | 2011-10-11 | 2011-11-23 | Royal Veterinary College The | Methods |
| EP2664327A1 (en) * | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
| GB201317005D0 (en) | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
-
2013
- 2013-09-25 GB GBGB1317005.5A patent/GB201317005D0/en not_active Ceased
- 2013-11-25 GB GBGB1320723.8A patent/GB201320723D0/en not_active Ceased
-
2014
- 2014-09-25 CN CN201480052228.3A patent/CN105579028B/zh active Active
- 2014-09-25 SM SM20190437T patent/SMT201900437T1/it unknown
- 2014-09-25 ES ES19153995T patent/ES2859518T3/es active Active
- 2014-09-25 HU HUE14781264 patent/HUE044589T2/hu unknown
- 2014-09-25 DK DK14781264.8T patent/DK3049056T4/da active
- 2014-09-25 PL PL14781264.8T patent/PL3049056T5/pl unknown
- 2014-09-25 US US15/023,602 patent/US11185511B2/en active Active
- 2014-09-25 EP EP19153995.6A patent/EP3501498B1/en active Active
- 2014-09-25 RS RS20190917A patent/RS59211B2/sr unknown
- 2014-09-25 JP JP2016516087A patent/JP6581569B2/ja active Active
- 2014-09-25 ES ES14781264T patent/ES2738662T5/es active Active
- 2014-09-25 SI SI201431280T patent/SI3049056T2/sl unknown
- 2014-09-25 WO PCT/GB2014/052911 patent/WO2015044669A1/en not_active Ceased
- 2014-09-25 EP EP20209656.6A patent/EP3854380A1/en active Pending
- 2014-09-25 LT LTEP14781264.8T patent/LT3049056T/lt unknown
- 2014-09-25 EP EP14781264.8A patent/EP3049056B2/en active Active
- 2014-09-25 HR HRP20191304TT patent/HRP20191304T4/hr unknown
- 2014-09-25 PT PT14781264T patent/PT3049056T/pt unknown
-
2019
- 2019-07-24 CY CY20191100783T patent/CY1123414T1/el unknown
- 2019-08-30 JP JP2019158280A patent/JP7028836B2/ja active Active
-
2021
- 2021-10-27 US US17/512,139 patent/US12161764B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536271A5 (cg-RX-API-DMAC7.html) | ||
| HRP20191304T4 (hr) | Antigljivični pripravak i postupci liječenja | |
| WO2009053741A3 (en) | Novel formulation | |
| JP2011516613A5 (cg-RX-API-DMAC7.html) | ||
| RU2013141845A (ru) | Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа | |
| WO2015152693A3 (ko) | 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물 | |
| JP2013516482A5 (cg-RX-API-DMAC7.html) | ||
| JP2011529038A5 (cg-RX-API-DMAC7.html) | ||
| MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
| RU2012149863A (ru) | Полисахарид семени тамаринда для применения в лечении микробных инфекций | |
| MX390004B (es) | Formulaciones y tratamientos topicos. | |
| WO2016116403A8 (en) | Polyurethaneurea solutions for compositions with active ingredients or fragrances | |
| MX2017004476A (es) | Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion. | |
| RU2016129193A (ru) | Составы на основе берберина и их применение | |
| HK1222337A1 (zh) | 用於施加药物活性成分或化妆品活性成分的局部组合物和载体 | |
| WO2015001163A3 (es) | Nanopartículas lipídicas para la cicatrización de heridas | |
| HK1255114A1 (zh) | 抗真菌剂 | |
| EP2825261A1 (en) | Polypeptides and their use | |
| HK1252057A1 (zh) | 新颖的使用方法和组合物 | |
| MX2015011624A (es) | Composiciones farmaceuticas secas que comprenden nanoparticulas de agente activo ligadas a particulas portadoras. | |
| JP2015511618A5 (cg-RX-API-DMAC7.html) | ||
| WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
| JP2017537163A5 (cg-RX-API-DMAC7.html) | ||
| JP2014530847A5 (cg-RX-API-DMAC7.html) | ||
| MX2021000769A (es) | Composicion farmaceutica que contiene clomipramina y metodo de preparacion de la misma. |